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Abstract
Background
Despite control efforts, human schistosomiasis remains prevalent throughout Africa, Asia,
and South America. The global schistosomiasis burden has changed little since the new
anthelmintic drug, praziquantel, promised widespread control.
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Methodology
We evaluated large-scale schistosomiasis control attempts over the past century and
across the globe by identifying factors that predict control program success: snail control
(e.g., molluscicides or biological control), mass drug administrations (MDA) with praziquantel, or a combined strategy using both. For data, we compiled historical information on control tactics and their quantitative outcomes for all 83 countries and territories in which: (i)
schistosomiasis was allegedly endemic during the 20th century, and (ii) schistosomiasis
remains endemic, or (iii) schistosomiasis has been "eliminated," or is "no longer endemic,"
or transmission has been interrupted.

Principal Findings
Widespread snail control reduced prevalence by 92 ± 5% (N = 19) vs. 37 ± 7% (N = 29) for
programs using little or no snail control. In addition, ecological, economic, and political factors contributed to schistosomiasis elimination. For instance, snail control was most
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common and widespread in wealthier countries and when control began earlier in the 20th
century.

Conclusions/Significance
Snail control has been the most effective way to reduce schistosomiasis prevalence.
Despite evidence that snail control leads to long-term disease reduction and elimination,
most current schistosomiasis control efforts emphasize MDA using praziquantel over snail
control. Combining drug-based control programs with affordable snail control seems the
best strategy for eliminating schistosomiasis.

Competing Interests: The authors have declared no
competing interests exist.

Author Summary
Schistosomiasis is a parasitic disease infecting more than 250 million people worldwide,
with almost 800 million at risk. Over the past century, nations undertook schistosomiasis
control programs, with outcomes varying from little effect to elimination. The biggest
hope for elimination began about 40 years ago with the discovery of the antischistosomal
drug praziquantel, after which snail control was seen as old fashioned. Here, we review
control program outcomes over the past 100 years across all major schistosomiasis
endemic zones, including Africa, Asia, and the Americas. We screened for differences in
long-term schistosomiasis reductions among countries and found the most successful programs focused on transmission control (most often snail control, with or without engineering interventions), sometimes in tandem with praziquantel. Although praziquantel
has important human-health benefits, our results suggest old-fashioned snail control has
been the key to schistosomiasis elimination.

Introduction
Can we do better at controlling schistosomiasis? Despite effective drug treatment options and
large-scale drug distribution programs, most endemic areas have not yet achieved satisfactory
schistosomiasis control. Today, schistosomiasis remains prevalent in Africa, Asia, and South
America where trends over time forecast perpetual endemicity. Sometimes, endemicity has
been because poverty constrains control efforts; otherwise, endemicity is due to failed or ineffective control attempts. With more than 250 million people still infected and elimination
stalled [1,2], the World Health Assembly (WHA) called for researching and applying complementary, non-pharmaceutical control strategies for eliminating schistosomiasis in its 2012
resolution 65.21 [3]. This resolution ignited debate over the best strategies for eliminating
schistosomiasis [4–9]. To add quantitative data to this debate, we evaluated schistosomiasis
control strategies over the past century and screened for factors associated with elimination or
long-term prevalence reductions.
Human schistosomiasis occurs where aquatic (or amphibious) intermediate host snails shed
infective Schistosoma spp. cercariae that penetrate human skin upon contact. Infected humans
suffer from anemia, stunted growth, cognitive impairment, fatigue, infertility, and sometimes,
liver fibrosis or bladder cancer [10]. Most affected people live in poverty where there are few
resources for research and control [11].
Schistosomiasis control efforts aim to disrupt the parasite’s complex life cycle (Fig 1): sanitation stops parasite eggs in urine or feces from moving into aquatic snail habitats; snail control
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Fig 1. Control strategies used against schistosomiasis during the past century.
doi:10.1371/journal.pntd.0004794.g001

reduces intermediate host density (parasite larvae reproduce asexually in snails); education (or
“information education and communication”; IEC) helps people avoid high-risk water contacts
and know when to seek treatment; and drugs—given as mass drug administrations (MDA),
targeted treatment campaigns (“test-and-treat” or TAT), or through health services—kill the
adult worm in the human host, with immediate and long-term health benefits for infected individuals [12]. Such efforts seem simple, but implementation often fails for economic or political
reasons.
Consensus on the “best” schistosomiasis control strategy has varied over the past century.
Early Egyptian control efforts around the turn of the 20th century treated human infection,
then shifted toward borehole latrines as a sanitary measure in the 1930s, but with little success
[13]. In the 1940s the focus shifted again, this time toward snail control using copper sulfate
[13]. Control strategy recommendations by the World Health Organization (WHO) then
emphasized integrated control measures, including clean water access, sanitation, snail control,
health education, and health services, in addition to drug treatments [12]. In the late 1970s and
early 1980s –after praziquantel became the drug-of-choice for treating schistosomiasis [14]–
the integrated approach was often supplanted by chemotherapy via MDA. Praziquantel is safe
and effective against adult schistosomes [15], but is ineffective against juvenile worms [16–18],
and drug treatment does not prevent reinfection [19–23]. Nonetheless, large-scale research
projects and influential modeling results suggested that widespread drug treatment (best when
coupled with sanitation measures) would reduce schistosomiasis more than other interventions
[24–27]. MDA increased in the 1990s after generic (inexpensive) praziquantel became available
[15,28]. Thus, in 2001, the WHA endorsed preventive chemotherapy as the primary strategy to
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Fig 2. Strategy details for schistosomiasis control: the current paradigm and an alternative based on past successes. (A) The current
paradigm for global schistosomiasis control, adapted from [30], and (B) an alternative strategy based on historical successes (this paper).
MDA = mass drug administration, TAT = targeted (“test-and-treat”) chemotherapy.
doi:10.1371/journal.pntd.0004794.g002

control schistosomiasis through reducing morbidity associated with high worm burdens [29].
Specifically, Engels et al. [30] summarized the modern, WHO-recommended schistosomiasis
global control strategy as MDA in high-transmission areas to reduce morbidity and transmission reduction in low-transmission areas (Fig 2a).
Although MDA is now the most popular control strategy, some have argued that snail control is more effective [5,6,31–33]. However, a Center for Global Development working group
focused on successful global health interventions points out: “We don’t know enough about
what’s worked because scaled up programs are rarely evaluated systematically” [34]. Here,
using objective criteria and a quantitative analysis to test for commonalities among successful
control programs, we find snail control has been effective at reducing schistosomiasis.

Methods
Defining Success
We evaluated control programs for all areas around the world with active (autochthonous)
human schistosomiasis transmission at some time in the 20th century. We considered countries
with little to no control effort as having minimal control. However if minimal control corresponded to a loss of schistosomiasis, we defined the outcome as fortuitous elimination. We
defined control as not (yet) successful where (i) control has been incomplete, (ii) transmission
continues, or (iii) the disease has been almost, but not yet, eliminated. We defined control as
successful for active programs that were reported to have stopped local transmission (i.e., elimination or becoming “non-endemic”) in WHO reports or peer-reviewed assessments (e.g.,
[9,35]). “Elimination” implies reducing disease incidence to zero in a particular area [30,36].
There is some inconsistency in the literature on the term “eradication,” which often refers to
global disease extirpation [37]. With respect to schistosomiasis, this has been applied to the
regional elimination achieved by Japan. Here, because elimination, “eradication,” and nonendemicity all imply no local transmission, we treated these designations as successful.

Countries and Territories Evaluated
Our goal was to evaluate control success in all countries and territories with endemic schistosomiasis during the 20th century. We began with the nine countries often cited as “success
stories” for schistosomiasis elimination: Iran, Japan, Lebanon, Malaysia, Martinique, Montserrat, Thailand, Tunisia, and Turkey [38]. Antigua, Jordan, and Morocco were three other
potential “successes” [35,39]. We were also interested in countries that achieved great reductions in schistosomiasis prevalence including Brazil, China, the Philippines, and Egypt.
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Additional literature searches focused on characterizing disease and control history for all
additional countries with: (i) historical disease data and (ii) recorded national- or territorylevel schistosomiasis control programs. Although we found relevant data for most countries,
data were contradictory for several Caribbean islands such as Guadeloupe and Dominican
Republic, with some reports indicating elimination and others claiming ongoing risk. We
considered these countries to be “not (yet) successful.” For several in-conflict countries such
as Chad and Syria, current schistosomiasis prevalence is “unknown”, with the potential for
conflict and political unrest to hinder control [40].

Data Collection
We obtained country-specific data for several categories (S1 Table) by reading peer-reviewed
published sources as well as non-peer-reviewed reports accessed through online (or hard copy)
repositories, including PubMed, ISI Web of Science, Google Scholar, WHO, United Nations
(UN), World Bank, United States Agency for International Development, and the UN Food and
Agriculture Organization (see S1 Appendix for complete reference list). From these sources, we
assessed 77 countries and six semi-autonomous territories (including Western Sahara in northern Africa, Guadeloupe, Martinique, Montserrat, Puerto Rico, and Zanzibar).
For each country, we collected information on schistosomiasis, control efforts, parasite
life cycles, environmental factors, and economics. We focused on variables related to national
schistosomiasis data (country- or territory-wide prevalence, infected population size, at-risk
population size) and details about the control strategies implemented and their time-course.
We also recorded snail and schistosome species present; island or mainland geography; and
per-capita gross domestic product (GDP) in 2013 and in all years for which schistosomiasis
disease data were available in each country. Further, we noted site-specific factors that might
alter disease outcomes or resources for control activities (S1 Table). We limited the prevalence information, in almost every case, to country-level (or territory-level) statistics. Only
for Japan, where finer scale data were available over many years, did we use large-scale and
long-term regional data to assess trends, and we included only the data from the largest
endemic area (the Kofu basin) in the statistical analyses. We were careful to avoid smallscale, focal studies on prevalence that might not represent the whole country. We treated
countries/territories as replicates in statistical analyses done in JMP Pro version 12 [41] and
R version 3.1.2 [42].

Statistics
To test the general hypothesis that control programs can eliminate schistosomiasis, we assessed
whether schistosomiasis was eliminated/non-endemic using a logistic regression, with five predictors for 68 countries/territories (excluding 15 that lacked enough data or were designated
non-endemic to begin with): (i) the presence/absence of a national- or territory-level control
program; (ii) status as a mainland or island (because it should be easier to achieve elimination
with more isolation); (iii) the total human population infected with schistosomiasis at baseline,
or before control began (because it might be harder to eliminate schistosomiasis when the starting infected population is large); (iv) the current fraction of people with access to improved
water sources (as a proxy for contemporary water, sanitation, and hygiene conditions, World
Bank Development Indicators, 2012 [43]); and (v) contemporary per-capita GDP (as a proxy
for “wealth” status, World Bank Development Indicators, 2013 [44]; S2 Table). Using 68 countries gave us considerable statistical power to evaluate when and where control has been effective in eliminating schistosomiasis.
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We next compared how well different control strategies reduced disease. The strategies used
in historical schistosomiasis control efforts were categorized as: MDA, snail control, or engineering interventions (e.g., sanitation infrastructure, cement lined canals, drained wetlands).
Each control category was further sorted according to our best estimate (based on qualitative
descriptions, or sometimes, quantitative reports): extensive/complete (>70% of the population/
area in need received treatment), intermediate (>30%), or focal to none (<30%). Although disease can be measured as intensity [45,46] (as indicated by patient egg output), there was not
enough published national-level data to assess intensity means and variances. Therefore, we
compared disease prevalence on a continuous scale (0 to 100% based on the schistosomiasis
national prevalence at each available time point for each country/territory). We included only
countries with national control programs and enough longitudinal disease data. We excluded
those countries/territories with no coordinated control effort (“Minimal control” in Table 1,
Fig 3). Further, among national control programs, we designated the category “low coverage”
where snail control, or MDA, or both were included, but the program achieved low (<30%)
coverage for either strategy. Similarly, engineering controls were considered present only
where their coverage was high (i.e. where more than 30% coverage was achieved).
To test the hypothesis that control strategies differed in their ability to reduce prevalence,
we used a quantitative generalized linear mixed model (GLMM, function “glmer” from the R
package “lme4” ([42], S2 Table). The statistical model assessed what factors best predicted relative change in prevalence over time for the 44 countries that applied concerted control and had
quantitative, longitudinal data on prevalence, control strategies and covariates (more details
below and in S2 Table). This GLMM considered country as a random effect (to account for the
repeated measures over time within each country) and the following fixed effects: (i) control
program duration (to test if longer efforts might be more successful); (ii) a country’s status as
an island or mainland; (iii) initial prevalence before control began (to account for the control
effort needed); (iv) the percentage of the population with access to improved water sources
(World Bank Indicators, 2012 [43]); and (v) the inflation-adjusted per capita GDP over time
(recorded at each time point with disease data from The Maddison-Project [47]). We were
most interested in the interaction terms between the predictors and time [year], which, if significant, would indicate an effect on prevalence reduction or increase over time. We first
assembled a “full model” that contained all predictors and interaction terms, and then used a
model selection procedure based on Akaike’s information criterion (AIC) to remove each
interaction term in turn to find the best balance between parsimony and fit to the data ([48], S3
Table).
After analyzing what control strategies were most successful, we became curious about the
factors that might have determined which control strategies a country used. To that end, we
assessed the correlations between the control strategies used and a country’s “wealth” status
(per-capita GDP for each country at each time-point) as well as the control era (the year each
national- or territory-level control program began).

Results
The response to schistosomiasis varied across the 83 evaluated countries/territories. Seventytwo countries and five territories were “endemic” for schistosomiasis during the 20th century
(whereas four were probably “never endemic,” and two had too little data to determine their
historical or contemporary schistosomiasis endemicity; Table 1, Fig 3). Only 51 (66%) of
endemic countries/territories had coordinated national- or territory-level schistosomiasis control during the past century, whereas the remaining 26 (34%) had no verifiable programs
(despite some having small pilot programs; Table 1, Figs 3 and 4). Nine endemic countries/
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Table 1. Countries and territories evaluated and their success categories, prevalence reduction, and percent reduction in population at risk for
schistosomiasis (as a proportion of the total population).
Prevalence reduction (%)
Country/
territory name

Historical or contemporary national
schistosomiasis control program?

Control program
outcome (success
category)

Baseline: postcontrol

Population at risk reduction
(%)

Baseline: Baseline: postnow
control

Baseline:
now

Algeria

ND

Not enough data

ND

ND

ND

ND

Angola

No

Minimal control

NA

ND

NA

ND

Antigua

No

Fortuitous elimination

NA

100

NA

100

Benin

Yes

Not (yet) successful

-2

-2

ND

ND

Botswana

No

Minimal control

NA

NA

NA

NA

Brazil

Yes

Not (yet) successful

92

80

72

69

Burkina Faso

Yes

Not (yet) successful

61.2

61.2

ND

ND

Burundi

Yes

Not (yet) successful

74.4

74.4

ND

ND

Cambodia

Yes

Not (yet) successful

83

83

90

90

Cameroon

Yes

Not (yet) successful

16.7

16.7

ND

ND

Cape Verde

---

Never endemic

NA

NA

NA

NA

Cen. African
Republic

Yes

Not (yet) successful

-58

-58

ND

ND

Chad

No

Minimal control

ND

China

Yes

Not (yet) successful

Comoros

---

Congo
Côte d'Ivoire
Dem. Rep. of the
Congo

NA

NA

NA

98.9

98.9

79

79

Never endemic

NA

NA

NA

NA

Yes

Not (yet) successful

-58

41.7

ND

ND

No

Minimal control

NA

NA

NA

NA

No

Minimal control

NA

NA

NA

NA

Djibouti

No

Fortuitous elimination

NA

NA

NA

NA

Dominican
Republic

Yes

Not (yet) successful

ND

ND

ND

ND

Egypt

Yes

Not (yet) successful

99

99

ND

ND

Equatorial
Guinea

No

Minimal control

NA

NA

NA

NA

Eritrea

No

Minimal control

NA

NA

NA

NA

Ethiopia

No*

Minimal control

NA

NA

NA

NA

Gabon

No

Minimal control

NA

NA

NA

NA

Gambia

No

Minimal control

NA

NA

NA

NA

Ghana

Yes

Not (yet) successful

73.9

73.9

ND

ND

Guadeloupe

Yes

Not (yet) successful

38

96

-16

ND

Guinea

No*

Minimal control

NA

NA

NA

NA

Guinea-Bissau

No

Minimal control

NA

NA

NA

NA

Indonesia

Yes

Not (yet) successful

99.5

99.5

90

ND

Iran

Yes

Successful

99.5

100

88.6

100

Iraq

Yes

Not (yet) successful

99.4

99.5

63

ND

Japan

Yes

Successful

100

100

100

100

Jordan

Yes

Successful

100

100

100

100

Kenya

Yes

Not (yet) successful

51

51

ND

ND

Laos

Yes

Not (yet) successful

96

84.6

4.7

ND
100

Lebanon

Yes

Successful

100

100

100

Lesotho

No

Minimal control

NA

NA

NA

NA

Liberia

No*

Minimal control

ND

ND

ND

ND
(Continued)
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Table 1. (Continued)
Prevalence reduction (%)

Population at risk reduction
(%)

Country/
territory name

Historical or contemporary national
schistosomiasis control program?

Control program
outcome (success
category)

Baseline: postcontrol

Libya

Yes

Not (yet) successful

66.7

66.7

NA

NA

Madagascar

Yes

Not (yet) successful

5.4

73.8

-14.6

ND

81.8

43.3

ND

ND

NA

NA

NA

NA

Baseline: Baseline: postnow
control

Baseline:
now

Malawi

Yes

Not (yet) successful

Malaysia

No

Fortuitous elimination

Mali

Yes

Not (yet) successful

50.6

51.8

-88

ND

Martinique

Yes

Successful

88.9

100

100

100

Mauritania

No

Minimal control

NA

NA

NA

NA

Mauritius

Yes

Successful

35.7

100

0

100

Montserrat

No

Fortuitous elimination

NA

NA

NA

NA

Morocco

Yes

Successful

100

100

100

100

Mozambique

Yes

Not (yet) successful

28.9

28.9

ND

ND

Namibia

No*

Minimal control

NA

NA

NA

NA

Niger

Yes

Not (yet) successful

50

44

ND

ND

Nigeria

No

Minimal control

NA

NA

NA

NA

Oman

Yes

Not (yet) successful

3

0.6

-1025

ND

Pakistan

---

Never endemic

NA

NA

NA

NA

Philippines

Yes

Not (yet) successful

93

98.3

11

ND

Puerto Rico

Yes

Successful

85.3

100

78.4

100

Rwanda

Yes

Not (yet) successful

69.5

69.5

ND

ND

Sao Tome &
Principe

No

Minimal control

NA

NA

NA

NA

Saudi Arabia

Yes

Not (yet) successful

81.05

99.8

-18

ND

Senegal

Yes

Not (yet) successful

1

1

ND

ND

Seychelles

---

Never endemic

NA

NA

NA

NA

Sierra Leone

Yes

Not (yet) successful

51.4

51.4

ND

ND

Somalia

Yes

Not (yet) successful

-24

-24

NA

NA

South Africa

No

Minimal control

NA

NA

NA

NA

St. Lucia

Yes

Not (yet) successful

88

98.2

84.3

84.3

Sudan

Yes

Not (yet) successful

-29.7

-29.7

47

47

Surinam

Yes

Not (yet) successful

61.5

61.5

69.3

69.3

Swaziland

Yes

Not (yet) successful

9.6

9.6

ND

ND

Syria

Yes

Not (yet) successful

65.4

ND

38

ND

Tanzania

Yes

Not (yet) successful

60

60

0

ND

Thailand

No

Fortuitous elimination

NA

NA

NA

NA

Togo

Yes

Not (yet) successful

30.9

30.9

ND

ND

Tunisia

Yes

Successful

100

100

100

100

Turkey

No

Fortuitous elimination

NA

NA

NA

NA

Uganda

Yes

Not (yet) successful

55.4

55.4

ND

ND

Venezuela

Yes

Not (yet) successful

90

98.6

ND

ND

Western Sahara

ND

not enough data

ND

ND

ND

ND

Yemen

Yes

Not (yet) successful

44

44

ND

ND

Zambia

Yes

Not (yet) successful

26.6

26.6

ND

ND

Zanzibar

Yes

Not (yet) successful

76.6

84.7

ND

ND
(Continued)
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Table 1. (Continued)
Prevalence reduction (%)
Country/
territory name

Historical or contemporary national
schistosomiasis control program?

Control program
outcome (success
category)

Zimbabwe

No*

Minimal control

Baseline: postcontrol
NA

Population at risk reduction
(%)

Baseline: Baseline: postnow
control
NA

Baseline:
now

NA

NA

Negative values represent increases.
“Baseline: post-control” compares just before to just after the control program.
“Baseline: now” refers to just before compared with contemporary estimates.
NA = not applicable.
ND = no data.
*Indicates that a control program has begun, but too recently (2012 or later) to evaluate its nationwide effect: in Ethiopia, control began 2015; in Guinea,
control began 2012; in Liberia, control began 2012; in Namibia, control using praziquantel is planned but not yet started in 2015; in Zimbabwe, control began
2012)
doi:10.1371/journal.pntd.0004794.t001

Fig 3. Countries and territories evaluated and their outcomes for schistosomiasis control or elimination. “Successful” = there was a control
program that preceded elimination or non-endemic status; “Fortuitous elimination” = elimination or non-endemic status with no control program;
“Minimal control” = endemic disease in the face of minimal to no control, even if there were some pilot or small-scale programs; “Not (yet) successful” =
endemic disease with a past or present control program.
doi:10.1371/journal.pntd.0004794.g003
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Fig 4. Schistosomiasis control programs over time. See Fig 5 for more details on control strategies and outcomes.
doi:10.1371/journal.pntd.0004794.g004

territories—Iran, Japan, Jordan, Lebanon, Martinique, Mauritius, Morocco, Puerto Rico, and
Tunisia—applied coordinated control programs and achieved “success” as we defined it here.
Nine countries/territories that have not yet achieved schistosomiasis elimination achieved a
90% or greater reduction in their country-level prevalence since baseline (before control):
China, Egypt, Guadeloupe, Indonesia, Iraq, Philippines, Saudi Arabia, St. Lucia, and Venezuela.
The remaining countries had variable schistosomiasis prevalence over the past century
(Table 1), depending, in part, on their control strategy.

PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004794

July 21, 2016

10 / 19

A Century of Schistosomiasis Control, What Works?

Table 2. Logistic regression for elimination/non-endemicity. *
Predictor

Estimate

Control program?–presence/absence
Population infected before control (log-transformed)
Improved water source (rural % with access), 2012

1.22

p value
0.42

-0.74

0.028*

0.16

0.027*

GDP per capita (2013)

-0.00004

0.55

Island? Yes/no

-0.15

0.87

*see S2 Table for more statistical details; N = 68 countries/territories evaluated
doi:10.1371/journal.pntd.0004794.t002

Elimination Predictors
Counter to expectations, elimination/non-endemicity was not associated with having a control
program. This unexpected result was due to two factors: several countries/territories achieved
“fortuitous” elimination without any documented control effort (Antigua, Djibouti, Malaysia,
Montserrat, Thailand, and Turkey) and several other countries failed to eliminate schistosomiasis, despite substantial prevalence reductions. Island/mainland did not predict elimination status (Table 2), however, our inclusion of population size, which is higher on continents and
makes elimination harder, could have co-varied with a mainland-island effect. Possessing
greater “wealth” (indicated by a higher contemporary per capita GDP) did not affect elimination. Elimination was, however, more likely where more people can access improved water
sources. In summary, achieving elimination was idiosyncratic. It was easier with smaller
infected populations and in countries with improved (safer) water sources. Although many
programs have failed to eliminate schistosomiasis, sometimes elimination has occurred without
a coordinated control program. Below, we discuss what factors in addition to control programs
could affect schistosomiasis prevalence reductions and elimination success.

Effective Control Strategies—Quantitative Outcomes
Although fortuitous elimination in several countries confounded our ability to assess whether
control programs eliminated schistosomiasis, many areas with control programs experienced
durable prevalence reductions. A program’s effectiveness (i.e., the prevalence reduction rate)
depended strongly on strategy type and coverage and weakly on the intercept (prevalence at
baseline). Applying snail control, MDA, or both—with at least intermediate (>30%) coverage
—worked better than any programs with low coverage. Snail control programs (primarily mollusciciding and biological control using non-native, competitor snails) showed the strongest
prevalence reductions (while accounting for other covariates, including: control duration [in
years], country “wealth” [as per capita GDP in each year with disease data], and access to
improved water sources; Table 3, Figs 5 and 6). In other words, all else being equal, prevalence
reduction was highest with snail control at intermediate or better coverage.
Although engineering controls (e.g., installing sanitation infrastructure, cementing canals,
building bridges, or draining wetlands), were almost always accompanied by snail control,
about half of the programs using snail control did not use engineering in their control programs. Programs that used MDA as a primary strategy (without snail control) also did not
report using any large-scale engineering controls. The presence or absence and extent of engineering controls showed weak effects on prevalence, and including 3-way interactions with this
variable—along with the other control strategies and time—in the quantitative statistical model
did not improve model fit to the data (based on AIC; S3 Table). Thus, engineering controls,
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Table 3. Generalized linear mixed model (GLMM, see S2 and S3 Tables) comparing change in prevalence for control programs using: MDA with
praziquantel, snail control primarily (snail control), both (MDA + snail control), or minimal control (<30% coverage, “low coverage,” not shown).
Estimate* (X 10−2) p-value

Description

Predictor

Interaction terms**

Control duration:time

0.02

<0.001

Island:time

1.1

<0.001

Improved water (contemporary % with access):time

0.09

<0.001

GDP per capita (inﬂation adjusted):time

1.2

Baseline prevalence:time

-0.04

Engineering controls:time

0.09

MDA:time
Snail control:time
Both (MDA + snail control):time

0.0013
<0.001
0.79

-2.3

<0.001

-12.3

<0.001

-7.9

<0.001

*The estimate indicates the change in prevalence over time where more negative (positive) values indicate stronger prevalence reduction (increase)
associated with that predictor.
Random effects for country/territory (intercept): variance = 2.06, std. dev. 1.44
N = 44 countries/territories evaluated.
**These are predictors association with change in prevalence over time (years) in each country/territory
doi:10.1371/journal.pntd.0004794.t003

although perhaps beneficial within some integrated programs, did not consistently reduce
schistosomiasis prevalence.
Population size affected control success. As expected, prevalence reductions were impaired
where there were larger initial infected human populations, but this relationship differed
among the control strategies. Snail control programs (with or without MDA) were less sensitive
to initial infected human population size, than were other approaches (Fig 7).

Wealth and Era Effects
Control strategy depended on country wealth and the year in which control began. Richer
countries (measured by inflation-adjusted, per-capita GDP) tended to begin their control programs earlier in the 20th century, with a stronger focus on snail control and greater success (Fig
8). Higher wealth was also correlated with greater access to improved (safer) water sources.
Large-scale MDA programs were rare before praziquantel entered the global market in the
1980s. After this turning point, there was a new option (using both MDA and snail control)
and this integrated strategy has been used since the 1980s in places like China, Egypt, and Brazil. Countries that began their control programs even more recently (after the 1990s or 2000s)
were poorer and tended either to focus on MDA or achieved poor coverage (designated as “low
coverage” in Fig 8).

Discussion
Our results support recent suggestions that snail control is key to schistosomiasis reduction
[5,6,49]. Such an effect has been anticipated. In 1985, a lead researcher of the Caribbean
“St. Lucia Project,”–a Rockefeller-funded schistosomiasis control study—wrote, “chemotherapy is now assuming the major role in control programmes, but in most. . . a reservoir of
infection inevitably remains. Transmission is thus likely to continue at a low, but probably
increasing level unless a supplementary control strategy is present” [24]. Unfortunately, it took
decades to assess this prediction.
Chemotherapy has major benefits for infected humans, but, by itself, MDA has done little
to curb re-infection. Although programs limited to MDA with praziquantel did not appear to
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Fig 5. Schistosomiasis prevalence change over time. Prevalence change by control program strategy (time 0 on the xaxis is set when control began; negative values for the normalized year show data n years before control started and
positive values n years after).
doi:10.1371/journal.pntd.0004794.g005
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Fig 6. Prevalence change by extent of snail control, or MDA, or both—see text for category definitions.
doi:10.1371/journal.pntd.0004794.g006

Fig 7. Sensitivity of schistosome prevalence reduction to the infected population size before the
control program began.
doi:10.1371/journal.pntd.0004794.g007
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Fig 8. Per capita gross domestic product (GDP) as it relates to control strategy and control start date in each country. Points represent
mean inflation-adjusted, per-capita GDP throughout the relevant time for which disease data were available, and bars represent the range.
doi:10.1371/journal.pntd.0004794.g008

do as well as the other strategies evaluated, the (targeted) chemotherapy for infection control
remains an undeniable factor in improving health, especially when integrated with snail control. Countries whose programs focused on snail control often relied on distributing chemotherapy through means other than MDA, such as Morocco’s successful test-and-treat (TAT)
campaigns using mobile teams [50], Iraq’s early school-based TAT programs [51], and Japan’s
involvement as an early TAT site for praziquantel beginning in the late 1970s. This involvement might have carried Japan to country-wide elimination by 1996 [52]. One reason praziquantel seems less effective than expected is that it was applied later in history when control
campaigns targeted more challenging countries. In other words, schistosomiasis elimination
was more successful among programs started before praziquantel reached the global market
than among those programs started after the drug’s introduction in the late 1970s. This might
arise, in part, because wealthier countries tended to address the disease earlier in the 20th century, as they could afford molluscicides for widespread snail control (although inexpensive biological control also sometimes succeeded).
The “fortuitous elimination” of schistosomiasis from Antigua, Djibouti, Malaysia, Montserrat, Thailand, and Turkey without documented control efforts suggests cryptic factors have
affected schistosomiasis, including: species invasions (e.g. snail competitors or predators), sanitation or health care improvements outside control programs, and human-induced or natural
ecosystem changes (such as changes in dams, irrigated-agriculture, and urbanization). The
least fortuitous of the fortuitous eliminations was the 1995 volcanic eruption that drove almost
half of Montserrat’s population off the island and made the schistosomiasis transmission zones
off limits to people [53,54]. (See S2 Appendix and S1 Fig for more cryptic schistosomiasis control examples).
These results suggest that programs have been most effective when snail control is coordinated soon thereafter—or simultaneously—with chemotherapy (morbidity control) via a
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rational progression from widespread, active drug distribution campaigns (MDA or targeted
treatment (TAT)) to a focus on high-risk groups and finally passive distribution within health
services coupled with surveillance (e.g. “surveillance and response”[55,56]) and health education (e.g. IEC) in the “end game” (Fig 2b).
As for how to control snails, the most common strategy has been to use expensive and toxic
molluscicides; an effort that is neither feasible nor desirable for many poor countries where
schistosomiasis is now endemic. Schistosomiasis has been hard to control without well-funded,
national-level efforts, and the contemporary global health discussion has been focused on strategies that optimize efficiency and affordability. By recognizing the successful use of snail control for transmission reduction, and by fostering research directed toward the development of
creative, safe and cheap tools to target the snail intermediate host, global schistosomiasis elimination might be attainable.
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